Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
79,794,643
-
Total 13F shares
-
12,700,475
-
Share change
-
+421,519
-
Total reported value
-
$54,741,949
-
Put/Call ratio
-
67%
-
Price per share
-
$4.31
-
Number of holders
-
63
-
Value change
-
+$1,963,386
-
Number of buys
-
33
-
Number of sells
-
21
Institutional Holders of Niagen Bioscience, Inc. - Common Stock (NAGE) as of Q4 2019
As of 31 Dec 2019,
Niagen Bioscience, Inc. - Common Stock (NAGE) was held by
63 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,700,475 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, ICONIQ Capital, LLC, Tieton Capital Management, LLC, STATE STREET CORP, Uniplan Investment Counsel, Inc., GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, Sycale Advisors (NY) LLC, and Mercator Fund (Cayman Master) LP.
This page lists
63
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.